Quick Summary:
Stay ahead in the dynamic global Human Papillomavirus (HPV) Testing industry by equipping yourself with invaluable insights from our latest market research report. This comprehensive guide provides an in-depth analysis of both emerging trends and established practices, giving you the strategic edge you need to outperform in this robustly expanding market, which is expected to reach US$1.6 Billion by 2030.
Your competitive advantage is our priority. Our report will empower you with detailed insights into growth prospects within different segments like Hospitals & Clinics and Diagnostic Centers, along with key geographic markets such as the U.S. and China. The report also evaluates and compiles the strategies of influential competitors, giving you a landscape view of your competition. Dive into this resourceful pool of knowledge and transformative market trends; seize this opportunity to lead in the high-growth HPV Testing market.
Global Human Papillomavirus (HPV) Testing Market to Reach $1.6 Billion by 2030
The global market for Human Papillomavirus (HPV) Testing estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Hospitals & Clinics, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$829.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Diagnostic Centers segment is readjusted to a revised 6.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $304.5 Million, While China is Forecast to Grow at 5.8% CAGR
The Human Papillomavirus (HPV) Testing market in the U.S. is estimated at US$304.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$284.5 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 5.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.Select Competitors (Total 46 Featured) -
- Abbott Laboratories
- Agilent Technologies, Inc.
- Arbor Vita Corporation
- Becton, Dickinson & Company
- Cepheid, Inc.
- Daan Gene Co., Ltd.
- Diagcor Bioscience Incorporation Ltd.
- Enzo Biochem, Inc.
- F. Hoffmann-La Roche AG
- Fujirebio US, Inc.
- Greiner Bio-One International GmbH
- Hologic, Inc.
- Hybribio Limited
- Medical & Biological Laboratories Co. Ltd.
- Norgen Biotek Corporation
- Promega Corporation
- Qiagen NV
- Seegene, Inc.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Zytovision GmbH
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Human Papillomavirus (HPV) Testing?
What is the growth rate of the Global Market for Human Papillomavirus (HPV) Testing?
What is the forecasted size of the Global Market for Human Papillomavirus (HPV) Testing?
Who are the key companies in the Global Market for Human Papillomavirus (HPV) Testing?
| Report Attribute | Details |
|---|---|
| No. of Pages | 173 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1 Billion |
| Forecasted Market Value ( USD | $ 1.6 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Arbor Vita Corporation
- Becton, Dickinson & Company
- Cepheid, Inc.
- Daan Gene Co., Ltd.
- Diagcor Bioscience Incorporation Ltd.
- Enzo Biochem, Inc.
- F. Hoffmann-La Roche AG
- Fujirebio US, Inc.
- Greiner Bio-One International GmbH
- Hologic, Inc.
- Hybribio Limited
- Medical & Biological Laboratories Co. Ltd.
- Norgen Biotek Corporation
- Promega Corporation
- Qiagen NV
- Seegene, Inc.
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
- Zytovision GmbH
